Loading data for VIR — first visit, this takes a few seconds.

Vir Biotechnology Inc.

NasdaqGS: VIR · Real-Time Price · USD
11.08
+0.37 (3.45%)
At close: Aug 27, 2026, 6:01 PM

The price, the headline numbers and the latest news, in one place.

Vir Biotechnology Inc. (VIR) Stock Price, Analysis & Data

3.45%

No data available

Bid7.93
Market Cap1.91B
Revenue (ttm)303.23M
Net Income (ttm)-251.68M
1.59
-1.77
n/a
-4.54
P/B (ttm)2.24
P/S (ttm)6.31
Earnings DateNov 4, 2026
Ask13.35
Volume2,248,366
Avg. Volume (20D)1,870,314
Open10.60
Previous Close10.71
Day's Range10.30 - 11.12
52-Week Range4.75 - 11.66
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About VIR

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody d...

Industry Biotechnology
Sector Healthcare
IPO Date Oct 11, 2019
Employees 367
Stock Exchange NasdaqGS
Ticker Symbol VIR
Full Company Profile

Financial Performance

In 2025, Vir Biotechnology's revenue was 66.52M, an increase of 4.41% compared to the previous year's 63.71M. Earnings were -437.99M, a decrease of -16.09%.

Financial Statements

Earnings Surprise

Vir Biotechnology has released their quarterly earnings on Aug 5, 2026:
  • Revenue of $238.94M misses estimates by $0, with 23075.07% YoY growth.
  • EPS of 0.47 misses estimates by -0.43, with 158.75% YoY growth.
Vir Biotechnology Inc. is scheduled to release its earnings on Nov 4, 2026, during market hours.
Analysts project revenue of ... Upgrade